Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The controlled attenuation parameter (CAP), based on transient elastography, is widely used for noninvasive assessment of the degree of hepatic steatosis (HS). We investigated the correlation of the degree HS between CAP and ultrasound (US) in patients with HS. Methods: In total, 986 patients with US-based HS who underwent transient elastography within 1 month were evaluated. The US-based grade of HS was categorized as mild (grade 1), moderate (grade 2), or severe (grade 3). Results: The CAP was significantly correlated with the US-based grade of HS (r = 0.458, p < 0.001). The median CAP value of each US-based HS grade showed a positive correlation with grade (271.1, 303.7, and 326.7 dB/m for grades 1, 2, and 3). In a multivariate analysis, the US-based HS grade, body mass index, serum albumin, alanine aminotransferase, and total cholesterol, and liver stiffness were all significantly correlated with the CAP value (all p < 0.05). The areas under the receiver operating characteristic curves for grade 2 to 3 and grade 3 HS were 0.749 (95% confidence interval [CI], 0.714 to 0.784) and 0.738 (95% CI, 0.704 to 0.772). The optimal cut-off CAP values to maximize the sum of the sensitivity and specificity for grade 2 to 3 and grade 3 HS were 284.5 dB/m (sensitivity 78.6%, specificity 61.7%) and 298.5 dB/m (sensitivity 84.6%, specificity 55.6%). Conclusions: The correlation of the degree of HS between CAP and US was significantly high in patients with HS, and the optimal cut-off CAP values for grade 2 to 3 and grade 3 HS were 284.5 and 298.5 dB/m.
Abstract
Background/Aims: The controlled attenuation parameter (CAP), based on transient elastography, is widely used for noninvasive assessment of the degree of hepatic steatosis (HS). We investigated the correlation of the degree HS between CAP and ultrasound (US) in patients with HS. Methods: In total, 986 patients with US-based HS who underwent transient elastography within 1 month were evaluated. The US-based grade of HS was categorized as mild (grade 1), moderate (grade 2), or severe (grade 3). Results: The CAP was significantly correlated with the US-based grade of HS (r = 0.458, p < 0.001). The median CAP value of each US-based HS grade showed a positive correlation with grade (271.1, 303.7, and 326.7 dB/m for grades 1, 2, and 3). In a multivariate analysis, the US-based HS grade, body mass index, serum albumin, alanine aminotransferase, and total cholesterol, and liver stiffness were all significantly correlated with the CAP value (all p < 0.05). The areas under the receiver operating characteristic curves for grade 2 to 3 and grade 3 HS were 0.749 (95% confidence interval [CI], 0.714 to 0.784) and 0.738 (95% CI, 0.704 to 0.772). The optimal cut-off CAP values to maximize the sum of the sensitivity and specificity for grade 2 to 3 and grade 3 HS were 284.5 dB/m (sensitivity 78.6%, specificity 61.7%) and 298.5 dB/m (sensitivity 84.6%, specificity 55.6%). Conclusions: The correlation of the degree of HS between CAP and US was significantly high in patients with HS, and the optimal cut-off CAP values for grade 2 to 3 and grade 3 HS were 284.5 and 298.5 dB/m.
참고문헌 (34)
- Lupsor-Platon M, "Noninvasive assessment of liver steatosis using ultrasound methods", Med Ultrason, 16, pp.236~245 (2014)
- Sasso M, "The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan", Clin Res Hepatol Gastroenterol, 36, pp.13~20 (2012)
- Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver", AJR Am J Roentgenol, 189, pp.W320~W323 (2007)
- Sookoian S, "Genetic predisposition in nonalcoholic fatty liver disease", Clin Mol Hepatol, 23, pp.1~12 (2017)
- Fan JG, "New trends on obesity and NAFLD in Asia", J Hepatol, 67, pp.862~873 (2017)
- Byrne CD, "NAFLD : a multisystem disease", J Hepatol, 62, pp.S47~S64 (2015)
- McPherson S, "Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies : implications for prognosis and clinical management", J Hepatol, 62, pp.1148~1155 (2015)
- Nasr P, "Natural history of nonalcoholic fatty liver disease : a prospective follow-up study with serial biopsies", Hepatol Commun, 2, pp.199~210 (2017)
- Jem Ma Ahn, "Acute hepatitis A; Cytotoxic T lymphocyte-associated antigen 4; Programmed death 1", Gut and Liver, 10(2), pp.295~302 (2016), 거트앤리버 소화기연관학회협의회
- Serfaty L, "Management of patients with non-alcoholic steatohepatitis(NASH)in real life", Liver Int, 38(Suppl 1), pp.52~55 (2018)
- Iacob S, "Real-life perception and practice patterns of NAFLD", NASH in Romania : results of a survey completed by 102 board-certified gastroenterologists, 2016, pp.25, 183~189
- Cengiz M, "Sonographic assessment of fatty liver : intraobserver and interobserver variability", Int J Clin Exp Med, 7, pp.5453~5460 (2014)
- Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver : a meta-analysis", Hepatology, 54, pp.1082~1090 (2011)
- Hamaguchi M, "The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation", Am J Gastroenterol, 102, pp.2708~2715 (2007)
- Mottin CC, "The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients", Obes Surg, 14, pp.635~637 (2004)
- de Ledinghen V, "Controlled attenuation parameter(CAP)for the diagnosis of steatosis : a prospective study of 5323 examinations", J Hepatol, 60, pp.1026~1031 (2014)
- Sasso M, "Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound Med Biol, 36, pp.1825~1835 (2010)
- Park SH, "What we need to know when performing and interpreting US elastography", Clin Mol Hepatol, 22, pp.406~414 (2016)
- Chon YE, "Controlled attenuation parameter(CAP)for detection of hepatic steatosis in patients with chronic liver diseases : a prospective study of a native Korean population", Liver Int, 34, pp.102~109 (2014)
- Chon YE, "Normal controlled attenuation parameter values : a prospective study of healthy subjects undergoing health checkups and liver donors in Korea", Dig Dis Sci, 60, pp.234~242 (2015)
- Carvalhana S, "How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population : correlation with ultrasound", Liver Int, 34, pp.e111~e117 (2014)
- Myers RP, "Controlled attenuation parameter(CAP) : a noninvasive method for the detection of hepatic steatosis based on transient elastography", Liver Int, 32, pp.902~910 (2012)
- Singh D, "Imaging of non alcoholic fatty liver disease : a road less travelled", Indian J Endocrinol Metab, 17, pp.990~995 (2013)
- Perez NE, "Ultrasound diagnosis of fatty liver in patients with chronic liver disease : a retrospective observational study", J Clin Gastroenterol, 41, pp.624~629 (2007)
- Rinella ME, "Practice patterns in NAFLD and NASH : real life differs from published guidelines", Therap Adv Gastroenterol, 9, pp.4~12 (2016)
- Oh H, "Non-alcoholic fatty liver diseases : update on the challenge of diagnosis and treatment", Clin Mol Hepatol, 22, pp.327~335 (2016)
- Lee DH, "Imaging evaluation of non-alcoholic fatty liver disease : focused on quantification", Clin Mol Hepatol, 23, pp.290~301 (2017)
- 한광협, "The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter", Yonsei Medical Journal, 57(4), pp.885~892 (2016), 연세대학교의과대학[DOI]
- Lee HW, "Prevalence and predictors of significant fibrosis among subjects with transient elastography-defined nonalcoholic fatty liver disease", Dig Dis Sci, 62, pp.2150~2158 (2017)
- Paul J, "Measurement of controlled attenuation parameter : a surrogate marker of hepatic steatosis in patients of nonalcoholic fatty liver disease on lifestyle modification : a prospective follow-up study", Arq Gastroenterol, 55, pp.7~13 (2018)
- Huh JH, "Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status", Metabolism, 66, pp.23~31 (2017)
- Yen YH, "Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients : a prospective cohort study", PLoS One, 12, pp.e0176027~ (2017)
- Ferraioli G, "The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis", Liver Int, 36, pp.1860~1866 (2016)
- de Ledinghen V, "Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography", Liver Int, 32, pp.911~918 (2012)